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Increased heme-oxygenase 1 expression in
mesenchymal stem cell-derived adipocytes
decreases differentiation and lipid accumulation
via upregulation of the canonical Wnt signaling
cascade
Luca Vanella1,2†, Komal Sodhi1†, Dong Hyun Kim1, Nitin Puri3, Mani Maheshwari1, Terry D Hinds Jr3, Lars Bellner4,
Dov Goldstein5, Stephen J Peterson4, Joseph I Shapiro1 and Nader G Abraham1*

Abstract
Introduction: Heme oxygenase (HO), a major cytoprotective enzyme, attenuates oxidative stress and obesity. The
canonical Wnt signaling cascade plays a pivotal role in the regulation of adipogenesis. The present study examined
the interplay between HO-1and the Wnt canonical pathway in the modulation of adipogenesis in mesenchymal
stem cell (MSC)-derived adipocytes.
Methods: To verify the role of HO-1 in generating small healthy adipocytes, cobalt protoporphyrin (CoPP), inducer
of HO-1, was used during adipocyte differentiation. Lipid accumulation was measured by Oil red O staining and
lipid droplet size was measured by BODIPY staining.
Results: During adipogenesis in vitro, differentiating pre-adipocytes display transient increases in the expression of
genes involved in canonical Wnt signaling cascade. Increased levels of HO-1 expression and HO activity resulted in
elevated levels of b-catenin, pGSK3b, Wnt10b, Pref-1, and shh along with increased levels of adiponectin (P < 0.05).
In addition, induction of HO-1 resulted in a reduction in C/EBPa, PPARg, Peg-1/Mest, aP2, CD36 expression and
lipid accumulation (P < 0.05). Suppression of HO-1 gene by siRNA decreased Wnt10b, pGSK3b and b-catenin
expression, and increased lipid accumulation. The canonical Wnt responsive genes, IL-8 and SFRP1, were
upregulated by CoPP and their expression was decreased by the concurrent administration of tin mesoporphyrin
(SnMP), an inhibitor of HO activity. Furthermore, knockdown of Wnt10b gene expression by using siRNA showed
increased lipid accumulation, and this effect was not decreased by concurrent treatment with CoPP. Also our
results show that blocking the Wnt 10b antagonist, Dickkopf 1 (Dkk-1), by siRNA decreased lipid accumulation and
this effect was further enhanced by concurrent administration of CoPP.
Conclusions: This is the first study to demonstrate that HO-1 acts upstream of canonical Wnt signaling cascade
and decreases lipogenesis and adipocyte differentiation suggesting that the HO-1 mediated increase in Wnt10b
can modulate the adipocyte phenotype by regulating the transcriptional factors that play a role in adipogenesis.
This is evidenced by a decrease in lipid accumulation and inflammatory cytokine levels, increased adiponectin
levels and elevation of the expression of genes of the canonical Wnt signaling cascade.
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Introduction
Human bone marrow-derived mesenchymal stem cells
(MSCs) are multipotent cells that have the potential to differentiate into a variety of cell types including adipocytes
[1-5]. MSC-derived adipocyte differentiation and dysregulation of adipogenesis is implicated in the pathogenesis of
diseases such as metabolic syndrome [4]. Enhanced adipogenesis with adipocyte hypertrophy is one of the leading
causes of adipose tissue hypoxia, inflammation, and dysfunction [6]. Hence, the elucidation of the mechanisms
that regulate commitment of MSCs towards adipogenic
fate may offer a portal to the development of treatment for
metabolic syndrome and its related vascular complications.
Adipogenesis begins with the commitment of MSCs to
the adipocyte lineage, followed by terminal differentiation
of pre-adipocytes to mature adipocytes [5,7]. Fat tissuederived adipocytes express several regulatory proteins
such as Wnts and b-catenin, as well as Sonic hedgehog
(Shh), which potentially works upstream of these known
differentiation factors to induce osteogenesis in MSCs
[8]. Wnts regulate gene expression through either the
canonical (b-catenin-dependent) or the non-canonical
(b-catenin-independent) pathway [9,10]. The canonical
Wnt signaling pathway controls cell proliferation, cell
survival and cell fate. Wnt ligands are secreted glycoproteins that function in a paracrine and autocrine manner.
Among the Wnt ligands identified, Wnt10b has been
shown to be a crucial factor in the activation of the
canonical pathway and inhibition of adipogenesis [11,12].
Adipose tissue-specific transgenic over-expression of
Wnt10b leads to a significant decrease in adiposity and
resistance to a high-fat diet in mice [13]. The canonical
Wnt pathway relies on stabilization of b catenin. The
Wnt/b catenin signaling pathway affects cellular functions by regulating both b catenin levels and subcellular
localization [14].
An increase in Wnt/b-catenin signaling inhibits the adipogenic transcription factor CCAAT/enhancer binding
protein (C/EBPa) and the peroxisome proliferator activator receptor (PPARg) [11,15-17]. Adipocyte differentiation
is an ordered multistep process requiring the sequential
activation of several groups of transcription factors,
including CCAAT/enhancer-binding protein (C/EBPa)
gene family and peroxisome proliferator activated receptor-g (PPAR-g) [1,18]. C/EBPa and PPARg are involved in
the growth arrest that is required for adipocyte differentiation. Pre-adipocyte factor-1 (Pref-1) belongs to the Notch
family of epidermal growth factor-like repeat-containing
proteins and has been shown to participate in maintaining
pre-adipose phenotype [19]. Pref-1 is an inhibitor of adipocyte differentiation, hence a decrease in Pref-1 expression is observed during differentiation of adipocytes [20].
The paternally expressed 1 (Peg-1)/Mesoderm-specific
transcript (Mest) [21], when upregulated, results in the

Page 2 of 14

enlargement of adipocytes during adipose tissue expansion
[22]. On accumulation of triglycerides, the levels of Peg-1/
Mest [22] are increased with a concomitant signal to preadipocytes to enlarge in order to accommodate more triglycerides. Adipocyte enlargement is associated with an
increase in the levels of TNFa, IL-1, IL-6 and increased
insulin resistance [23-26]. Hedgehog signaling exerts its
pleiotropic effects through regulation of the cell cycle,
direction of cell differentiation, and alteration of cell survival [27]. Conversely, Shh signaling represses adipogenic
differentiation in pre-adipocytes [28].
Heme oxygenase-1 (HO-1) is a stress response gene critical for bone marrow cell differentiation [29-31]. A porphyrin structure within cyanocobalamine enables it to
induce HO-1 gene expression by facilitating its binding to
the porphyrin binding domain of the HO-1 gene. Induction of HO-1 enhances cell survival and moderates diabetes and obesity [32]. Induction of HO-1 gene expression
in vivo and in cell culture results in an increase in pre-adipocytes, a reduction in the number of enlarged adipocytes,
and an increase in small adipocyte and adiponectin levels
[33]. A decrease in HO-1 expression results in increased
insulin resistance and adiposity in Zucker rats and obese
mice [34]. Additionally, induction of HO-1 in adipocyte
cell culture is associated with increased adiponectin levels
and decreased pro-inflammatory cytokines, TNFa and
IL-6 [35,36].
The goal of this study was to elucidate the role of HO-1
gene expression on adipogenesis and clarify the role of
Wnt10b and its dependent genes in this process. Induction of HO-1 gene expression and HO activity decreased
lipid deposition and inflammatory cytokine levels,
increased adiponectin levels and elevated the expression
of genes of the canonical Wnt signaling cascade. These
novel findings demonstrate that increased levels of HO-1
appear crucial in modulating the phenotype of adipocytes
to express canonical downstream signaling proteins.

Materials and methods
Differentiation of human bone marrow-derived MSCs into
adipocytes

Frozen bone marrow mononuclear cells were purchased
from Allcells (Allcells, Emeryville, CA, USA). After thawing, mononuclear cells were resuspended in an a-minimal
essential medium (a-MEM, Invitrogen, Carlsbad, CA,
USA) supplemented with 10% heat-inactivated FBS (Invitrogen) and 1% antibiotic/antimycotic solution (Invitrogen).
The cells were plated at a density of 1 to 5 × 106 cells per
100-cm2 dish. The cultures were maintained at 37°C in a
5% CO2 incubator and the medium was changed after 48 h
and every 3 to 4 days thereafter. When the MSCs were
confluent, the cells were recovered by the addition of
0.25% trypsin/ethylenediaminetetraacetic acid (EDTA)
(Invitrogen). MSCs (passage 2 to 3) were plated in a
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75-cm2 flask at a density of 1 to 2 × 104 cells and cultured
in a-MEM with 10% FBS for 7 days. The medium was
replaced with adipogenic medium, and the cells were cultured for an additional 14 days as described previously [37].
Human MSCs, passage 3, were cultured in the presence of
the HO-1 inducer cobalt protoporphyrin (CoPP) (5 μM)
and with the HO activity inhibitor tin (Sn4+)-mesoporphyrin (SnMP) (5 μM), which were administered every
2 days.
HO activity measurement

Heme oxygenase activity was measured in hMSCs by carbon monoxide (CO) production in cellular homogenates.
Briefly, hMSCs were homogenized in Sucrose (255 mM)Tris hydrochloride (20 mM) buffer (pH 7.4) with NP-40
(1% w/v), EDTA (1 mM), phenylmethylsulfonyl fluoride
(PMSF) (1 mM) and mammalian protease inhibitor cocktail (5% v/v). After homogenization, samples were centrifuged, at 6000 × g for 30 minutes at 4°C, and the
supernatant collected for measurement of HO activity;
100 μg protein/sample was incubated, in gas-sealed vials,
in Sucrose-Tris buffer along with nicotinamide adenine
dinucleotide phosphate-oxidase (NADPH) (1 mM) and
excess heme (40 μM), in both the absence and the presence of SnMP (2 μM). Samples were incubated in a
water bath, in the absence of light, at 37°C for 60 minutes, after which, the HO reaction was stopped by placing
the samples in ice. CO generation was quantitated in the
headspace using gas chromatography/mass spectrometry
(GC/MS), as previously described [38], using C13O16 as
an internal standard. Results are expressed as HO-dependent CO generation by subtracting the amount of CO in
the presence of SnMP. CO generated is expressed as
pmoles/mg protein/hour.
Effect of CoPP on adipogenesis

To measure the effect of increased HO-1 expression on
MSC-derived adipocyte differentiation, cells were treated
with 0.5, 1.0, 2.0, 5.0, and 10.0 μM of CoPP every 4 days.
After 14 days, cells were stained with Oil Red O solution.
Oil Red O staining

Staining was performed using 0.21% Oil Red O in 100%
isopropanol (Sigma-Aldrich, St. Louis, MO, USA). Briefly,
adipocytes were fixed in 10% formaldehyde, stained with
Oil Red O for 10 minutes, rinsed with 60% isopropanol
(Sigma-Aldrich), and the Oil Red O eluted by adding
100% isopropanol for 10 minutes and the optical density
(OD) measured at 490 nm, for 0.5 sec reading.
Measurement of lipid droplet size

After induction of adipogenesis, lipid droplets were
stained with 2 μM boron-dipyrromethene (BODIPY)
493/503 (Molecular Probes, Eugene, OR, USA) [39]. Cell
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size was measured using an ImagePro Analyzer (MediaCybernetics, Inc., Bethesda, MD, USA). The classification
of the size of lipid droplets was based on size by area
(pixels).
Cell viability test by lactic dehydrogenate assay (LDH)

We followed the manufacturer’s protocol (LDH Assay
kit, Cayman, Ann Arbor, MI, USA). Briefly, hMSC and
adipocytes at day 14 were plated in 96-well plates for
1 day. Next day, cell layers were washed twice with PBS,
and then cells were treated with various concentrations
of CoPP (0 to 10 μM). After incubation for 24 h, and
addition of 100 μl of reaction mixture to each well, cells
were incubated for 4 hours at 37°C and 5% CO 2 in a
humidified incubator. Absorbance was measured in the
96-well microplate using a microplate reader at 490 nm
with 650 nm as the reference wavelength, and the percentage of LDH release for each sample was normalized
according to the absorbance reading from samples treated with 0.5% Triton X-100. All analyses were replicated
eight times.
Cytokine array and adiponectin

TNFa and adiponectin (high molecular weight, HMW),
were measured as previously described [25,40] by Cytokine SearchLight Infrared arrays (Pierce Biotechnology,
Inc., Woburn, MA, USA).
HO-1 siRNA transfection

Cells were treated with three different predesigned
siRNAs of the HO-1 gene (SASI_ Hs01_00035068,
SASI_Hs01_00035065 and SASI_Hs01_00035067 from
Sigma-Aldrich, St. Louis, MO, USA). According to the
manufacturer’s protocol, adipogenic media containing
siRNA using NTER (Sigma-Aldrich) was replaced every
48 h. Briefly, a nanoparticle solution was incubated with
10 nM siRNA. After 20 minutes cells were treated with
siRNA solution during adipogenesis, which was halted
after 10 days.
Measurement of MSC-derived adipocyte signaling
molecules

Cells were maintained at -80°C until required for assay.
Frozen cells were pulverized and placed in a homogenization buffer (10 mM phosphate buffer, 250 mM sucrose,
1 mM EDTA, 0.1 mM PMSF and 0.1% tergitol, pH 7.5).
Homogenates were centrifuged at 27,000 × g for 10 minutes at 4°C. The supernatant was isolated and protein
levels were assayed (Bradford Method). The supernatant
was used for measurement of HO-1, Wnt10b, b-catenin,
Pref-1, C/EBPa, Peg-1/Mest, pGSK3b, shh, PPARg and
b-actin levels as described previously [25,41]. b-Actin
was used to ensure adequate sample loading for all
western blots.
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Quantitative real-time PCR analysis

Total RNA was extracted from differentiated human
mesenchymal stem cells using 5-Prime PerfectPure RNA
Tissue Kit (Fisher Scientific Company, LLC, Wilmington,
DE, USA). Total RNA was read on a NanoDrop 2000
spectrophotometer (Thermo Fisher Scientific) and cDNA
was synthesized using High Capacity cDNA ReverseTranscription Kit (Life Technologies, Grand Island, NY,
USA). PCR amplification of the cDNA was performed by
quantitative real-time PCR using TrueAmp SYBR Green
qPCR SuperMix (Smart Bioscience, Philadelphia, USA).
The thermocycling of IL-8 and Secreted frizzled-related
protein 1 (SFRP1) protocol consisted of 5 minutes at
95°C, 40 cycles of 15 sec at 95°C, and 30 sec at 60°C, and
finished with a melting curve ranging from 60 to 95°C to
allow distinction of specific products. Normalization was
performed in separate reactions with primers to 18S
mRNA (TTC GAACGTCTGCCCTATCAA and ATGG
TAGGCACGGCGACTA).
Statistical analyses

Statistical significance (P < 0.05) of differences between
experimental groups was determined by the Fisher
method for analysis of multiple comparisons. For comparison between treatment groups, the null hypothesis
was tested by either single-factor analysis of variance
(ANOVA) for multiple groups, or the unpaired t-test for
two groups, and the data are presented as mean ± standard error (SE).

Results
The effect of adipogenesis on HO-1 expression

The temporal sequence of HO-1 expression was determined over a 14-day period in MSC-derived adipocytes.
The basal levels of HO-1 expression increased during
MSC adipogenic culture growth and peaked at day 3
(Figure 1B). This was followed by gradual decrease in HO1 expression, while lipid droplet area gradually increased
over a period of 14 days (Figure 1A).
The effect of CoPP on cell viability during adipogenesis
by LDH assay

Detection of cell membrane integrity is a rapid and simple
approach to determine cell viability by measuring cellular
LDH leakage in damaging cells. Our results showed that
CoPP treatment in MSCs and adipocytes at day 14 have
no cytotoxic effects at concentrations up to 5 μM (Figure
1C). However, MSCs and adipocytes showed significant
toxicity at a 10 μM concentration of CoPP (P < 0.05).
The effect of CoPP on HO-1 expression, HO activity and
cytokine levels during adipogenesis

We examined the effect of CoPP on lipid accumulation
after 14 days, using standard culture conditions by
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measuring Oil Red O-stained lipid droplet area (Figure
2A). The level of cells with Oil Red O-stained lipid droplets decreased as CoPP concentration increased. CoPP
decreased lipid accumulation in a concentration-dependent manner. Oil Red O staining was barely detectable at
the highest concentration of CoPP (10 μM), although
untreated MSC-derived adipocyte progenitor cells were
loaded with lipid droplets (control). Quantification of Oil
Red O-stained cells showed an increase in the number of
adipocytes in the absence of CoPP (77,093 ± 943 pixels)
compared with the presence of CoPP (54,376 ± 5,366 and
3,526 ± 368 pixels) at 1 and 10 μM, respectively. The
expression of HO-1 in the presence of CoPP increased in
a dose-dependent manner (Figure 2B), which was consistent with our results showing decreased lipogenesis with
increased concentrations of CoPP (Figure 2A). HO activity, as measured by CO release, was increased in the
presence of CoPP compared to the control (Figure 2C;
P < 0.05). HO activity increased reaching a maximum
(P < 0.05) at day 10 and remained elevated. This was in
contrast to the control where HO activity remained at
the same level as day 0. One possible explanation of this
discrepancy between HO-1 expression and HO activity
could be differential effects of progressing adipogenesis
on HO-1 expression and activity. Other investigators
[42,43] have reported redox imbalances during the
process of adipogenesis. We have previously shown that
oxidative stress can induce HO expression while suppressing HO activity [44] (Figure 2C).
Adipose cell enlargement is associated with increased
secretion of cytokines, which impairs the differentiation of
pre-adipocytes and reduces adiponectin secretion. We
examined the levels of TNFa in the conditioned media of
CoPP-treated MSC-derived adipocytes, and found that
TNFa levels were significantly decreased (Figure 2D; P <
0.001) at day 14. In contrast, CoPP increased adiponectin
levels were increased subsequent to CoPP treatment when
compared to controls at day 14 (P < 0.05; Figure 2E).
Effect of CoPP and SnMP on adipogenesis and
distribution of lipid droplet size, stained by BODIPY

After 14 days, the number of lipid droplets stained with
Oil Red O was lower after CoPP treatment when compared to control (P < 0.05; Figure 3A-B). In contrast, HO
activity inhibitor, SnMP treatment, resulted in higher
levels of Oil Red O staining when compared to control
(Figure 3A-B). To confirm that increased levels of HO-1
resulted in decreased lipid accumulation, we stained lipid
droplets with BODIPY/4’,6-diamidino-2-phenylindole
(DAPI) (Figure 3C). CoPP treatment decreased the number of very large lipid droplets (P < 0.05) and increased
the number of small lipid droplets when compared with
control (Figure 3D). In contrast, SnMP significantly
increased the number of large lipid droplets (P < 0.05)
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Figure 1 Expression of heme oxygenase-1 (HO-1), with time, on adipogenesis. (A) Pictures of lipid droplets of a representative experiment
at days 3, 5, 10, and 14. Adipogenesis was measured as the relative absorbance of Oil Red O as described in Materials and methods (mean ±
SD, *P < 0.05 vs control). (B) Western blot of HO-1 and actin in mesenchymal stem cell (MSC)-derived adipocytes from day 0 to day 14.
Representative immunoblots and densitometry analysis are shown. Data are expressed as means ± SD; n = 4; *P < 0.05. (C) Lactic dehydrogenate
(LDH) assay done to study the cytotoxicity at increasing concentrations of cobalt-protoporphyrin IX (CoPP). Data are expressed as means ± SD;
n = 8, *P < 0.05 vs MSC control, **P < 0.05 vs adipocytes control.

and decreased the number of small lipid droplets, compared with either culture treated with CoPP or control,
indicating that this effect is mediated by increased HO
activity (Figure 3D). The results were quantified and are
shown in Figure 3E.
Effect of CoPP and SnMP on CD36 expression

CD36, a fatty acid translocase, which mediates the transfer of fatty acids (FAs) into the cell [45], was measured in
MSCs and MSC-derived adipocytes treated with either
CoPP (5 μM) or SnMP (5 μM). Cells were treated with
adipogenic media and collected after 14 days. As seen in
Figure 4A, during lipogenesis CoPP decreased CD36
expression (25.21 ± 1.67%) compared to control (44.29 ±
4.33%), while SnMP increased CD36 expression (52.83 ±
3.12%). The results are quantified in Figure 4B and show
that CoPP decreased CD36 levels (P < 0.05) compared to
control indicating decreased fatty acid uptake in adipocytes by upregulation of HO-1. As expected, SnMP
restored CD36 levels to those seen in control, suggesting

that increased HO-1 expression and activity has anti-adipogenic response on adipocytes.
Effect of siRNA HO-1 on adipogenesis

Upregulation of HO-1 by CoPP decreased lipid accumulation, which was measured as the relative absorbance of Oil
Red O. To selectively assess the role of HO-1 on adiposity,
HO-1 siRNA was added to the cell culture. Lipid accumulation was increased after HO-1 siRNA treatment as compared to MSCs treated with CoPP (Figure 5A; P < 0.05).
Densitometry analysis showed that CoPP treatment
increased HO-1 expression in MSC-derived adipocytes
compared to the control, and this effect was reversed by
siRNA HO-1 (Figure 5B; P < 0.01). The protein expression
of Shh increased with CoPP treatment and was reversed
by siRNA HO-1 (Figure 5C). Pref-1, an excellent marker
for pre-adipocytes, which is extinguished during adipocyte
differentiation [19], was increased by CoPP treatment and
was decreased by siRNA HO-1 (Figure 5G). Upregulation
of HO-1 by CoPP treatment decreased levels of the
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adipogenic markers Peg-1/Mest, aP2, C/EBPa and PPARg
in MSC-derived adipocytes, and this effect was reversed by
transduction with HO-1 siRNA (Figure 5D, E, E, G and
5H respectively; P < 0.02).

levels of these Wnt responsive genes, IL-8 and SFRP1,
were increased by CoPP treatment and these effects
were reversed by concurrent treatment with SnMP
(Figure 6D and E respectively; P < 0.05).

Effect of siRNA HO-1 on canonical Wnt signaling and
Wnt-responsive genes

Effect of CoPP on canonical Wnt signaling cascade during
adipogenesis

Upregulation of HO-1 by CoPP treatment increased
protein expression of the canonical Wnt signaling cascade, Wnt10b, pGSK3b and b-catenin in MSC-derived
adipocytes as compared to the control. To selectively
assess the role of HO-1 on adiposity, HO-1 siRNA was
added to cell culture with a resultant decrease in
Wnt10b, pGSK3b and b-catenin levels (Figure 6A, B
and 6C respectively; P < 0.05). Canonical Wnt signaling
cascade is known to activate IL-8 and SFRP1 [46]. The

Our results show Oil Red O staining was increased after
siRNA HO-1 treatment compared to MSCs treated with
CoPP (Figure 7A). To elucidate the role of Wnt10b in the
regulation of adipogenesis in MSC-derived adipocytes, we
measured the effect of suppression of Wnt10b on adipogenesis, using siRNA. The addition of siRNA Wnt10b
increased lipid formation compared to the vehicle (P <
0.05), and this effect was not significantly altered by concurrent administration of CoPP, suggesting a possible
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interaction between HO-1 and the Wnt10b pathway. Wnt
antagonist, Dickkopf 1 (Dkk1), is secreted by human preadipocytes and promotes adipogenesis [47]. Further our
results show that knockdown of Wnt antagonist Dkk1 by
siRNA showed significant reduction in lipid accumulation
compared to siRNA Wnt10b, and more importantly,
administration of CoPP further significantly deceased lipogenesis (P < 0.05; Figure 7A).
The protein expression of b-catenin and phosphorylated glycogen synthase kinase (GSK3)b was measured
to study the effect of Wnt10b inhibition by using siRNA
(Figure 7B and 7C respectively). Our results showed
decreased expression of b-catenin and pGSK3b when
MSCs were treated with Wnt10b siRNA compared to
the control (P < 0.05) and this effect was not reversed
by concurrent treatment with CoPP. We next determined whether inhibition of Dkk1 using siRNA affected
these adipogenic markers. Our results further showed
that b-catenin and pGSK3b levels were increased compared to the MSCs treated with siRNA Wnt10b. More
importantly, concurrent administration of CoPP significantly increased the gene expression of b-catenin and

pGSK3b (P < 0.05) compared to the cells treated with
siRNA Dkk1.

Discussion
This study demonstrates that the effects of HO-1 induction in a cell-based model of adipogenesis are dependent
upon activation of the Wnt canonical signaling pathway.
HO-1 induction has reduced body weight and adiposity
[25,48] and improved the metabolic profile in animal models of obesity [24,49]. It has also been shown that upregulation of HO-1 reduces adipogenesis in cell cultures [34].
We show here in a cell-based model of adipogenesis
(MSCs) that HO-1 induction mediates the recruitment of
the Wnt canonical cascade, and entails reduced lipid accumulation comprised of smaller healthier adipocytes,
reduced inflammation and improved adipokine secretion.
Differentiation of pre-adipocytes into adipocytes is
regulated by a balance of transcriptional factors that can
both positively and negatively influence differentiation.
This is reflected by the appearance of various early, intermediate and late mRNA/protein markers and triglyceride
accumulation. Several reports describe an association
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between adipogenesis and Wnt signaling in the regulation of adult tissue homeostasis and remodeling [50,51].
Wnt10b is an endogenous regulator of adipogenesis that
maintains pre-adipocytes in an undifferentiated state and
functions as an adipogenic switch. The activation of
Wnt10b contributes to the inactivation/phosphorylation
of GSK3b and consequently, elevated level of b-catenin;
it is the molecular node of the canonical Wnt signaling
pathway. When Wnt signaling is active, GSK3 is inhibited. Conversely, when Wnt signaling is suppressed,
GSK3 phosphorylates b-catenin and targets it for ubiquitin-mediated degradation [11]. Our results describe a critical link between the anti-adipogenic effects of HO-1
and stimulation of the Wnt canonical pathway. Two lines
of evidence characterize this relationship: First, HO-1
induction in CoPP-treated cells was accompanied by
increased levels of Wnt10b and its associated signaling
mediators, namely, phosphorylated GSK3b and b-catenin.
The concurrent reduction in adipocyte size and lipid
accumulation establishes a link between this phenotype,
that is, HO-1 induction and Wnt signaling. Second,

siRNA-mediated downregulation/inhibition of Wnt10b
prevented HO-1 from reducing adipocyte hypertrophy in
MSCs. Further our results show that inhibition of Dkk1
by siRNA decreased lipogenesis, and this effect was
further enhanced by concurrent administration of CoPP.
These observations indicate that activation of the Wnt
canonical pathway plays a role in the prevention of adipocyte hypertrophy and the promotion of smaller healthier adipocytes in MSCs undergoing HO-1 induction.
The precise molecular mechanism linking HO-1 to activation of Wnt signaling is unclear. However, the restoration of the redox environment as a result of HO-1
induction [37] could contribute to activation of Wnt signaling. In this regard, it should be noted that chronic oxidative stress has been shown to suppress the Wnt
canonical pathway [52,53] while enhancing lipid accumulation and hypertrophy in MSC-derived adipocytes.
Furthermore, our studies show that upregulation of HO1and increased HO activity lead to increased levels of the
Wnt-responsive genes, IL-8 and SFRP1, which was
reversed by the HO-1 inhibitor, SnMP. Thus, these
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results substantiate our hypothesis that Wnt10b may be
considered an HO-1 gene target that when increased, ultimately results in a reduction in adipocyte hypertrophy.
Activation of Wnt/b-catenin signaling maintains preadipocytes in an undifferentiated state through inhibition
of the adipogenic transcription factors, C/EBPa and
PPARg [15-17]. C/EBPa and PPARg have been shown to
activate adipocyte-specific genes and are involved in the
growth arrest that is required for adipocyte differentiation.
Our results show that the increased expression of HO-1
resulted in either maintaining pre-adipocytes in the undifferentiated state or slowed down this process, presumably
through activation of Wnt/b-catenin and inhibition of C/
EBPa and PPARg levels. Pref-1 has also been shown to

participate in maintaining the pre-adipose phenotype.
A decrease in Pref-1 expression is observed during adipocyte differentiation. In adipose tissue, Pref-1 is specifically
expressed in pre-adipocytes but not in adipocytes and
thus, is used as a pre-adipocyte marker [54]. In concordance with these observations, our results showed that
upregulation of HO-1 increased Pref-1 expression, suggesting that HO-1 decreased adipocyte differentiation.
Pref-1 prevents lipid accumulation and expression of adipocyte transcription factors such as PPARg and C/EBPa,
as well as other late adipocyte markers, including FA
synthase and FABP4/aP2 [54]. CD36 and aP2 are PPARg
target genes and their mRNA levels were significantly
increased during adipocyte differentiation, leading to
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Figure 6 Effect of heme oxygenase-1 (HO-1) induction and suppression on adipogenic marker expression in mesenchymal stem cell
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b-catenin levels, respectively. Data are expressed as means ± SD (*P < 0.01 vs control, **P < 0.05 vs siRNA HO-1). (D-E) Effect of HO-1 induction
and inhibition on Wnt -responsive genes IL-8 and Secreted frizzled-related protein 1 (SFRP1). Data are expressed as means ± SD (*P < 0.05 vs
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increased lipid storage and lipogenesis [55]. Lipid accumulation of avian adipocytes is mainly dependent upon the
FA transmembrane uptake process mediated by membrane proteins, such as fatty acid translocase (FAT/CD36)
[45]. Our studies show that increased HO-1 gene expression decreased aP2 and CD36 levels, suggesting that HO-1
mediated increase of Wnt10b could inhibit fatty acid accumulation and lipogenesis. Our study also showed that
upregulation of HO-1 is associated with increased adiponectin levels and decreased inflammatory cytokine, TNFa.
Increased pro-inflammatory and reduced anti-inflammatory cytokines reflect the functional consequences of upregulation of HO-1 in MSC-derived adipocytes [34]. Smaller
adipocytes are considered to be healthy, insulin-sensitive
adipocytes that are capable of producing adiponectin [48].
In light of this evidence, elevation of adiponectin along

with suppression of TNFa synthesis by adipocytes cultured in the presence of HO-1 induction complements the
effect of the latter on adipocyte size. Together, these findings implicate the role of HO-1-Wnt signaling in bringing
about reduced lipid accumulation and improved adipocyte
function in MSC-derived adipocytes. Wnts, b-catenin and
Shh, are essential to regulate the conversion of pre-adipocytes to adipocytes [16,47]. In this regard, we also examined Shh, which potentially works upstream of these
known differentiation factors to reduce adipogenesis [8,27].
Upregulation of HO-1 increased Shh protein expression,
which was reversed by siRNA of HO-1, confirming its role
in decreasing adipocyte hypertrophy.
Our results show that the increase in Wnt10b in parallel
with the increase in HO-1 gene expression by CoPP
was associated with a significant reduction in levels of

Vanella et al. Stem Cell Research & Therapy 2013, 4:28
http://stemcellres.com/content/4/2/28

Page 11 of 14

CoPP
Vehicle

Oil Red O (490nm)

A

siRNA
HO-1

Scr

0.12

siRNA
HO-1

V

siRNA
Wnt10b

siRNA
Dkk-1

‡

#

0.08

siRNA
Dkk-1

‡

*

*

0.1

siRNA
Wnt10b

0.06

&

**

0.04
0.02
0

Vehicle Scr siRNA siRNA siRNA
HO-1 Wnt10b. Dkk-1

V siRNA siRNA
HO-1 Wnt10b

siRNA
Dkk-1

CoPP
CoPP

CoPP

B
Scr

siRNA
siRNA Wnt siRNA
HO-1 10b
Dkk-1

siRNA
siRNA Wnt siRNA
V HO-1 10b Dkk-1

Scr

C

Ecatenine

siRNA
siRNA Wnt siRNA
10b
HO-1
Dkk-1

0.9

**
*

pGSK/ actin

E catenine/ actin

*

‡
‡

0.4
0.2

0.7

#

0.6
0.5
0.4
0.3
0.2

&

**

0.8

&

1.0

0.0

siRNA
Wnt siRNA
10b
Dkk-1

Eactin

1.2

0.6

siRNA
HO-1

pGSK

Eactin

0.8

V

*

‡
‡

*

0.1

Scr siRNA siRNA siRNA V
HO-1 Wnt10b Dkk-1

siRNA siRNA
HO-1 Wnt10b

siRNA
Dkk-1

CoPP

0.0

Scr siRNA siRNA siRNA
HO-1 Wnt10b Dkk-1

V siRNA siRNA siRNA
HO-1 Wnt10b Dkk-1

CoPP

Figure 7 Effect of heme oxygenase-1 (HO-1) on the Wnt canonical pathway during adipogenesis. (A) Effect of inhibition of HO-1, Wnt10b
and Dickkopf 1 (Dkk1) using respective siRNA on adipocyte hypertrophy. Lipogenesis was measured as the relative absorbance of Oil Red O at
day 14 after inducing adipogenesis as described in Materials and methods (mean ± SD, *P < 0.05 vs vehicle, #P < 0.05 vs siRNA Wnt10b, **P <
0.05 vs siRNA HO-1, ‡P < 0.05 vs cobalt-protoporphyrin IX (CoPP), &P < 0.05 vs siRNA Dkk1). (B-C) Effect of inhibition of HO-1, Wnt10b and Dkk1
using respective siRNA on b-catenin and p- glycogen synthase kinase (GSK) levels respectively. Data are expressed as means ± SD. (*P < 0.05 vs
scramble, #P < 0.05 vs siRNA Wnt10b, **P < 0.05 vs siRNA HO-1, ‡P < 0.05 vs CoPP, &P < 0.05 vs siRNA Dkk1).

Peg-1/Mest. A decrease in Peg-1/Mest is beneficial in the
control of obesity, since upregulation of Peg-1/Mest
occurs in obese adipose tissue in several models of obesity
[21,56]. Our data demonstrate that the induction of HO-1
was effective in suppressing adipocyte differentiation, as
evidenced by an increase in the canonical Wnt cascade
and a decrease in Peg-1/Mest. These effects were reversed
by blocking HO-1 gene expression by siRNA, further
demonstrating that HO-1 mediated-increase in Wnt10b,
and decrease in Peg-1/Mest resulted in the maintenance
of pre-adipocytes in their undifferentiated state with the
slowing of the differentiation process. Taken together,
these observations provide compelling evidence that HO1-mediated increase in Wnt signaling and its associated
genes modulate adipogenesis.

Conclusions
In conclusion, as represented in the schematic (Figure 8),
our novel study demonstrates that upregulation of HO-1
gene expression and increased HO activity decreased adipocyte differentiation, with an associated increase in the
number of small healthy lipid droplets via interplay of the
Wnt signaling cascade. This is evident by the fact that
increased HO-1 expression and HO activity decreased adipocyte hypertrophy, decreased TNFa levels, increased adiponectin level and increased expression of the genes
central to the canonical Wnt signaling cascade. Thus,
crosstalk between HO-1 and Wnt10b could be employed
therapeutically to suppress adipogenesis, and therefore
constitutes an attractive drug development target to combat obesity-associated metabolic complications.
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Figure 8 Proposed mechanism demonstrating the interplay of heme oxygenase 1 (HO-1) and the Wnt canonical pathway in the
modulation of adipogenesis in mesenchymal stem cells (MSC)-derived adipocytes. HO-1 suppresses adipocyte differentiation by increasing
expression of key regulators including Wnt10b, p-glycogen synthase kinase (GSK), b-catenin and Sonic hedgehog (shh) and decreasing
expression of adipogenic transcription factors CCAAT/enhancer binding protein a (CEBP)a, peroxisome proliferator-activated receptor (PPAR)g
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Abbreviations
aP2: fatty-acid-binding protein 4 (FABP4); BODIPY: boron-dipyrromethene; C/
EBP: adipogenic transcription factors CCAAT/enhancer binding protein a;
CoPP: cobalt-protoporphyrin IX; DAPI: 4’,6-diamidino-2-phenylindole; Dkk-1:
Dickkopf 1; EDTA: ethylenediaminetetraacetic acid; EET: epoxyeicosatrienoic
acids; FA: fatty acid; FAT/CD36: fatty acid translocase; FACS: fluorescenceactivated cell sorter; FBS: fetal bovine serum; GC/MS: gas chromatography/
mass spectrometry; GSK3 β: glycogen synthase kinase 3β; HMW: high
molecular weight; HO-1: heme oxygenase-1; IL: interleukin; LDH: lactic
dehydrogenate; Mest: Mesoderm-specific transcript; MSC: mesenchymal stem
cells; NADPH: nicotinamide adenine dinucleotide phosphate-oxidase; OD:
optical density; PBS: phosphate-buffered saline; PCR: polymerase chain
reaction; Peg 1: Paternally expressed 1; PMSF: phenylmethylsulfonyl fluoride;
PPAR: peroxisome proliferator activator receptor; Pref-1; Pre-adipocyte factor1; SE: standard error; SFRP1: Secreted frizzled-related protein 1; Shh: Sonic

hedgehog; SnMP: tin (stannic)-mesophorphyrin IX; TNF: tumor necrosis
factor; Wnts: Wingless-type.
Authors’ contributions
LV contributed equally to this work performing cell culture and HO levels
and contributed in conception and design. KS contributed equally to this
work, drafted the manuscript and repeated all work done by LV to confirm
the results. D-HK performed Oil red stain and measurements. NP designed
the siRNA, treatments, and harvested stem cells from culture. MM performed
western blots for signaling. LB performed the cytotoxic assay. SJP was
involved in design and input for the significance for clinical application.
NGA, PI, designed, accumulated data, compared figures and examined
various experiments. JIS revised the discussion and input to redraw several
figures and scheme. All authors read and approved the final manuscript for
publication.

Vanella et al. Stem Cell Research & Therapy 2013, 4:28
http://stemcellres.com/content/4/2/28

Page 13 of 14

Competing interests
The authors declare that they have no competing interests.

18. Rosen ED, MacDougald OA: Adipocyte differentiation from the inside out.
Nat Rev Mol Cell Biol 2006, 7:885-896.
19. Wang Y, Kim KA, Kim JH, Sul HS: Pref-1, a preadipocyte secreted factor
that inhibits adipogenesis. J Nutr 2006, 136:2953-2956.
20. Smas CM, Sul HS: Pref-1, a protein containing EGF-like repeats, inhibits
adipocyte differentiation. Cell 1993, 73:725-734.
21. Kamei Y, Suganami T, Kohda T, Ishino F, Yasuda K, Miura S, Ezaki O,
Ogawa Y: Peg1/Mest in obese adipose tissue is expressed from the
paternal allele in an isoform-specific manner. FEBS Lett 2007, 581:91-96.
22. Takahashi M, Kamei Y, Ezaki O: Mest/Peg1 imprinted gene enlarges
adipocytes and is a marker of adipocyte size. Am J Physiol Endocrinol
Metab 2005, 288:E117-E124.
23. Peterson SJ, Drummond G, Kim DH, Li M, Kruger AL, Ikehara S,
Abraham NG: L-4F treatment reduces adiposity, increases adiponectin
levels and improves insulin sensitivity in obese mice. J Lipid Res 2008,
49:1658-1669.
24. Peterson SJ, Kim DH, Li M, Positano V, Vanella L, Rodella LF, Piccolomini F,
Puri N, Gastaldelli A, Kusmic C, L’Abbate A, Abraham NG: The L-4F
mimetic peptide prevents insulin resistance through increased levels
of HO-1, pAMPK, and pAKT in obese mice. J Lipid Res 2009,
50:1293-1304.
25. Li M, Kim DH, Tsenovoy PL, Peterson SJ, Rezzani R, Rodella LF, Aronow WS,
Ikehara S, Abraham NG: Treatment of obese diabetic mice with a heme
oxygenase inducer reduces visceral and subcutaneous adiposity,
increases adiponectin levels, and improves insulin sensitivity and
glucose tolerance. Diabetes 2008, 57:1526-1535.
26. Vanella L, Kim DH, Asprinio D, Peterson SJ, Barbagallo I, Vanella A,
Goldstein D, Ikehara S, Kappas A, Abraham NG: HO-1 expression increases
mesenchymal stem cell-derived osteoblasts but decreases adipocyte
lineage. Bone 2010, 46:236-243.
27. Neumann CJ: Hedgehogs as negative regulators of the cell cycle. Cell
Cycle 2005, 4:1139-1140.
28. Fontaine C, Cousin W, Plaisant M, Dani C, Peraldi P: Hedgehog signaling
alters adipocyte maturation of human mesenchymal stem cells. Stem
Cells 2008, 26:1037-1046.
29. Chhikara M, Wang S, Kern SJ, Ferreyra GA, Barb JJ, Munson PJ, Danner RL:
Carbon monoxide blocks lipopolysaccharide-induced gene expression
by interfering with proximal TLR4 to NF-kappaB signal transduction in
human monocytes. PLoS One 2009, 4:e8139.
30. Abraham NG: Molecular regulation–biological role of heme in
hematopoiesis. Blood Rev 1991, 5:19-28.
31. Abraham NG, Kappas A: Pharmacological and clinical aspects of heme
oxygenase. Pharmacol Rev 2008, 60:79-127.
32. Li M, Peterson S, Husney D, Inaba M, Guo K, Kappas A, Ikehara S,
Abraham NG: Long-lasting expression of HO-1 delays progression of type
I diabetes in NOD mice. Cell Cycle 2007, 6:567-571.
33. Berg AH, Scherer PE: Adipose tissue, inflammation, and cardiovascular
disease. Circ Res 2005, 96:939-949.
34. Kim DH, Burgess AP, Li M, Tsenovoy PL, Addabbo F, McClung JA, Puri N,
Abraham NG: Heme oxygenase-mediated increases in adiponectin
decrease fat content and inflammatory cytokines, tumor necrosis factoralpha and interleukin-6 in Zucker rats and reduce adipogenesis in
human mesenchymal stem cells. J Pharmacol Exp Ther 2008, 325:833-840.
35. Vanella L, Kim DH, Sodhi K, Barbagallo I, Burgess AP, Falck JR,
Schwartzman ML, Abraham NG: Crosstalk between EET and HO-1
downregulates Bach1 and adipogenic marker expression in
mesenchymal stem cell derived adipocytes. Prostaglandins Other Lipid
Mediat 2011, 96:54-62.
36. Kim DH, Vanella L, Inoue K, Burgess A, Gotlinger K, Manthati VL, Koduru SR,
Zeldin DC, Falck JR, Schwartzman ML, Abraham NG: Epoxyeicosatrienoic
acid agonist regulates human mesenchymal stem cell-derived
adipocytes through activation of HO-1-pAKT signaling and a decrease in
PPARgamma. Stem Cells Dev 2010, 19:1863-1873.
37. Kim DH, Vanella L, Inoue K, Burgess A, Gotlinger K, Manthati VL, Koduru SR,
Zeldin DC, Falck JR, Schwartzman ML, Abraham NG: EET-Agonist Regulates
Human Mesenchymal Stem Cells-Derived Adipocytes Through Activation
of HO-1-pAKT Signaling and a decrease in PPARgamma. Stem Cells Dev
2010, 19:1863-1873.
38. Chertkov JL, Jiang S, Lutton JD, Levere RD, Abraham NG: Hemin
stimulation of hemopoiesis in murine long-term bone marrow culture.
Exp Hematol 1991, 19:905-909.

Acknowledgements
All authors had full access to the data and take responsibility for its integrity.
All authors have read and agreed with the manuscript as written. This work
was supported by National Institutes of Health grants DK56601, HL-34300
and BrickStreet Foundation Inc. We thank Jennifer Brown for her
outstanding editorial assistance in the preparation of the manuscript.
Author details
1
Joan C. Edwards School of Medicine, Marshall University, 1600 Medical
Center Drive, Huntington, WV, 25701-3655, USA. 2Department of Drug
Science, Section of Biochemistry, University of Catania, Viale Andrea Doria, 6,
95125 Catania, Italy. 3Department of Physiology and Pharmacology,
University of Toledo, 3000 Arlington Avenue, Toledo, OH, 43614-2598, USA.
4
Department of Medicine, New York Medical College, Munger Pavilion,
Valhalla, NY, 10595, USA. 5Brooklyn Fertility Center, Columbia University, 55
Central Park West, New York, NY 10023, USA.
Received: 10 August 2012 Revised: 7 December 2012
Accepted: 21 January 2013 Published: 12 March 2013
References
1. Mandrup S, Lane MD: Regulating adipogenesis. J Biol Chem 1997,
272:5367-5370.
2. Billon N, Monteiro MC, Dani C: Developmental origin of adipocytes: new
insights into a pending question. Biol Cell 2008, 100:563-575.
3. Wislet-Gendebien S, Wautier F, Leprince P, Rogister B: Astrocytic and
neuronal fate of mesenchymal stem cells expressing nestin. Brain Res Bull
2005, 68:95-102.
4. Ailhaud G: Adipose tissue as a secretory organ: from adipogenesis to the
metabolic syndrome. C R Biol 2006, 329:570-577.
5. Gesta S, Tseng YH, Kahn CR: Developmental origin of fat: tracking obesity
to its source. Cell 2007, 131:242-256.
6. Puri N, Sodhi K, Haarstad M, Kim DH, Bohinc S, Foglio E, Favero G,
Abraham NG: Heme induced oxidative stress attenuates sirtuin1 and
enhances adipogenesis in mesenchymal stem cells and mouse preadipocytes. J Cell Biochem 2012, 113:1926-1935.
7. Vestergaard P: Bone metabolism in type 2 diabetes and role of
thiazolidinediones. Curr Opin Endocrinol Diabetes Obes 2009, 16:125-131.
8. James AW, Leucht P, Levi B, Carre AL, Xu Y, Helms JA, Longaker MT: Sonic
Hedgehog influences the balance of osteogenesis and adipogenesis in
mouse adipose-derived stromal cells. Tissue Eng Part A 2010, 16:2605-2616.
9. Clevers H: Wnt/beta-catenin signaling in development and disease. Cell
2006, 127:469-480.
10. Cadigan KM, Liu YI: Wnt signaling: complexity at the surface. J Cell Sci
2006, 119:395-402.
11. Bennett CN, Ross SE, Longo KA, Bajnok L, Hemati N, Johnson KW,
Harrison SD, MacDougald OA: Regulation of Wnt signaling during
adipogenesis. J Biol Chem 2002, 277:30998-31004.
12. MacDonald BT, Tamai K, He X: Wnt/beta-catenin signaling: components,
mechanisms, and diseases. Dev Cell 2009, 17:9-26.
13. Longo KA, Wright WS, Kang S, Gerin I, Chiang SH, Lucas PC, Opp MR,
MacDougald OA: Wnt10b inhibits development of white and brown
adipose tissues. J Biol Chem 2004, 279:35503-35509.
14. Prestwich TC, MacDougald OA: Wnt/beta-catenin signaling in
adipogenesis and metabolism. Curr Opin Cell Biol 2007, 19:612-617.
15. Kawai M, Mushiake S, Bessho K, Murakami M, Namba N, Kokubu C,
Michigami T, Ozono K: Wnt/Lrp/beta-catenin signaling suppresses
adipogenesis by inhibiting mutual activation of PPARgamma and C/
EBPalpha. Biochem Biophys Res Commun 2007, 363:276-282.
16. Ross SE, Hemati N, Longo KA, Bennett CN, Lucas PC, Erickson RL,
MacDougald OA: Inhibition of adipogenesis by Wnt signaling. Science
2000, 289:950-953.
17. Okamura M, Kudo H, Wakabayashi K, Tanaka T, Nonaka A, Uchida A,
Tsutsumi S, Sakakibara I, Naito M, Osborne TF, Hamakubo T, Ito S,
Aburatani H, Yanagisawa M, Kodama T, Sakai J: COUP-TFII acts
downstream of Wnt/beta-catenin signal to silence PPARgamma gene
expression and repress adipogenesis. Proc Natl Acad Sci USA 2009,
106:5819-5824.

Vanella et al. Stem Cell Research & Therapy 2013, 4:28
http://stemcellres.com/content/4/2/28

39. Tavian D, Colombo R: Improved cytochemical method for detecting
Jordans’ bodies in neutral lipid storage diseases. J Clin Pathol 2007,
60:956-958.
40. Sambuceti G, Morbelli S, Vanella L, Kusmic C, Marini C, Massollo M,
Augeri C, Corselli M, Ghersi C, Chiavarina B, Rodella LF, L’Abbate A,
Drummond G, Abraham NG, Frassoni F: Diabetes impairs the vascular
recruitment of normal stem cells by oxidant damage; reversed by
increases in pAMPK, heme oxygenase-1 and adiponectin. Stem Cells
2009, 27:399-407.
41. Sodhi K, Inoue K, Gotlinger K, Canestraro M, Vanella L, Kim DH, Manthati VL,
Koduru SR, Falck JR, Schwartzman ML, Abraham NG: Epoxyeicosatrienoic
acid agonist rescues the metabolic syndrome phenotype of HO-2-null
mice. J Pharmacol Exp Ther 2009, 331:906-916.
42. Lowe CE, O’Rahilly S, Rochford JJ: Adipogenesis at a glance. J Cell Sci 2011,
124:2681-2686.
43. Gummersbach C, Hemmrich K, Kroncke KD, Suschek CV, Fehsel K, Pallua N:
New aspects of adipogenesis: radicals and oxidative stress. Differentiation
2009, 77:115-120.
44. Puri N, Zhang F, Monu SR, Sodhi K, Bellner L, Lamon BD, Zhang Y,
Abraham NG, Nasjletti A: Antioxidants Condition pleiotropic vascular
responses to exogenous H(2)O(2): role of modulation of vascular TP
Receptors and the heme oxygenase system. Antioxid Redox Signal 2012,
18:471-480.
45. Pohl J, Ring A, Korkmaz U, Ehehalt R, Stremmel W: FAT/CD36-mediated
long-chain fatty acid uptake in adipocytes requires plasma membrane
rafts. Mol Biol Cell 2005, 16:24-31.
46. Modder UI, Oursler MJ, Khosla S, Monroe DG: Wnt10b activates the Wnt,
notch, and NFkappaB pathways in U2OS osteosarcoma cells. J Cell
Biochem 2011, 112:1392-1402.
47. Christodoulides C, Laudes M, Cawthorn WP, Schinner S, Soos M, O’Rahilly S,
Sethi JK, Vidal-Puig A: The Wnt antagonist Dickkopf-1 and its receptors
are coordinately regulated during early human adipogenesis. J Cell Sci
2006, 119:2613-2620.
48. Nicolai A, Li M, Kim DH, Peterson SJ, Vanella L, Positano V, Gastaldelli A,
Rezzani R, Rodella LF, Drummond G, Kusmic C, L’Abbate A, Kappas A,
Abraham NG: Heme Oxygenase-1 Induction Remodels Adipose Tissue
and Improves Insulin Sensitivity in Obesity-Induced Diabetic Rats.
Hypertension 2009, 53:508-515.
49. Sodhi K, Puri N, Inoue K, Falck JR, Schwartzman ML, Abraham NG: EET
agonist prevents adiposity and vascular dysfunction in rats fed a high
fat diet via a decrease in Bach 1 and an increase in HO-1 levels.
Prostaglandins Other Lipid Mediat 2011, 98:133-142.
50. Logan CY, Nusse R: The Wnt signaling pathway in development and
disease. Annu Rev Cell Dev Biol 2004, 20:781-810.
51. Taipale J, Beachy PA: The Hedgehog and Wnt signalling pathways in
cancer. Nature 2001, 411:349-354.
52. Vertino AM, Taylor-Jones JM, Longo KA, Bearden ED, Lane TF, McGehee RE
Jr, MacDougald OA, Peterson CA: Wnt10b deficiency promotes
coexpression of myogenic and adipogenic programs in myoblasts.
Mol Biol Cell 2005, 16:2039-2048.
53. Zhang Y, Sun Y, Wang F, Wang Z, Peng Y, Li R: Downregulating the
canonical Wnt/beta-catenin signaling pathway attenuates the
susceptibility to autism-like phenotypes by decreasing oxidative stress.
Neurochem Res 2012, 37:1409-1419.
54. Sul HS: Minireview: Pref-1: role in adipogenesis and mesenchymal cell
fate. Mol Endocrinol 2009, 23:1717-1725.
55. Lee J, Jung E, Lee J, Kim S, Huh S, Kim Y, Kim Y, Byun SY, Kim YS, Park D:
Isorhamnetin represses adipogenesis in 3T3-L1 cells. Obesity (Silver Spring)
2009, 17:226-232.
56. Koza RA, Nikonova L, Hogan J, Rim JS, Mendoza T, Faulk C, Skaf J, Kozak LP:
Changes in gene expression foreshadow diet-induced obesity in
genetically identical mice. PLoS Genet 2006, 2:e81.
doi:10.1186/scrt176
Cite this article as: Vanella et al.: Increased heme-oxygenase 1
expression in mesenchymal stem cell-derived adipocytes decreases
differentiation and lipid accumulation via upregulation of the canonical
Wnt signaling cascade. Stem Cell Research & Therapy 2013 4:28.

Page 14 of 14

Submit your next manuscript to BioMed Central
and take full advantage of:
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at
www.biomedcentral.com/submit

